Allarity Therapeutics
ALLR | NASDAQ
$0.88
-$0.07 (-7.74%)
At close: Nov 16, 2026, 4:00 PM ET
$0.94
+$0.06 (+6.41%)
After-hours:
Nov 16, 2026, 7:40 PM ET
-7.74%
(1D)No price chart data available for 1D timeframe.
Rating
40.5
+8.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #512/1021 (Top 50%)
Key Statistics
Market Data
Market Cap $13.93M
1D Range
0.87 0.97
52W Range
0.81 1.77
Valuation (TTM)
PE -0.90
PB -6.16
EV/EBITDA -1.70
Valuation (NTM)
Forward PE N/A
Forward PEG -0.77
Price Target $11.00
Cash Flow
FCF Yield -95.1%
SBC Adj. FCF Yield -99.3%
SBC Impact -4.4%
Margins
Gross Margin 98.3%
Operating Margin -3938.3%
FCF Margin -3785.4%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 150.0% |
95.2%
FCF 3Y | 5Y 8.4% |
7.3%
Returns
ROA -57.8%
ROE -349.1%
ROIC -66.4%
Financial Health
Net Debt
$8.92M
Current Ratio 0.91
Interest Coverage -6.83
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific c...
Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Dec 21, 2021
Website www.allarity.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.39
Miss -85.71%
YoY:
-105.26% REV
$5K
Beat 0.00%
Next Earnings
Mar 29, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+1150.00%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ALLR